These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18924466)

  • 1. [Nosologic comorbidity in addictive medicine].
    Eryshev OF
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; Suppl 1():21-5. PubMed ID: 18924466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of alcohol dependence comorbidity and antipsychotic medication on volumes of the thalamus and pons in schizophrenia.
    Sullivan EV; Rosenbloom MJ; Serventi KL; Deshmukh A; Pfefferbaum A
    Am J Psychiatry; 2003 Jun; 160(6):1110-6. PubMed ID: 12777269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].
    Wobrock T; D'Amelio R; Falkai P
    Nervenarzt; 2008 Jan; 79(1):17-8, 20-2, 24-6 passim. PubMed ID: 17619840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.
    Green AI
    J Clin Psychiatry; 2006; 67 Suppl 7():31-5; quiz 36-7. PubMed ID: 16961422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The integration of pharmacological therapy for comorbid psychiatric and addictive disorders.
    Miller NS; Guttman JC
    J Psychoactive Drugs; 1997; 29(3):249-54. PubMed ID: 9339856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional striatal volume abnormalities in schizophrenia: effects of comorbidity for alcoholism, recency of alcoholic drinking, and antipsychotic medication type.
    Deshmukh A; Rosenbloom MJ; De Rosa E; Sullivan EV; Pfefferbaum A
    Schizophr Res; 2005 Nov; 79(2-3):189-200. PubMed ID: 15963693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram.
    Petrakis IL; Nich C; Ralevski E
    Schizophr Bull; 2006 Oct; 32(4):644-54. PubMed ID: 16887890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine and amisulpride in refractory schizophrenia and alcohol dependence.
    Dervaux A; Cazali J
    J Clin Psychopharmacol; 2007 Oct; 27(5):514-6. PubMed ID: 17873688
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antidepressants in the treatment of alcoholism].
    Sivolap IuP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5 Pt 2):32-5. PubMed ID: 22951795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating depression in schizophrenia.
    Lund BC; Perry PJ; Miller DD
    Am J Psychiatry; 2001 Sep; 158(9):1528-9. PubMed ID: 11532750
    [No Abstract]   [Full Text] [Related]  

  • 11. [Schizophrenia and alcohol abuse: clinical data].
    Favre JD
    Encephale; 2003 Sep; 29(Pt 2):S20-2. PubMed ID: 14710531
    [No Abstract]   [Full Text] [Related]  

  • 12. Concomitant psychotropic medication use during treatment of schizophrenia patients: longitudinal results from the CATIE study.
    Chakos M; Patel JK; Rosenheck R; Glick ID; Hammer MB; Tapp A; Miller A; Miller D
    Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):124-34. PubMed ID: 21983496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of lamotrigine to augment clozapine in patients with resistant schizophrenia and comorbid alcohol dependence: a potent anti-craving effect?
    Kalyoncu A; Mirsal H; Pektas O; Unsalan N; Tan D; Beyazyürek M
    J Psychopharmacol; 2005 May; 19(3):301-5. PubMed ID: 15888516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognosis of the effectiveness of pharmacotherapy of patients with acute schizophrenia based on a correlation and regression analysis of clinical and electroencephalographic indices].
    Nemtsov AV; Kalinin VV; Zaĭtsev SG; Golikova TI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982 Sep; 82(9):68-73. PubMed ID: 6128846
    [No Abstract]   [Full Text] [Related]  

  • 15. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
    Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI
    J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balance and gait deficits in schizophrenia compounded by the comorbidity of alcoholism.
    Sullivan EV; Rosenbloom MJ; Pfefferbaum A
    Am J Psychiatry; 2004 Apr; 161(4):751-5. PubMed ID: 15056526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of depression after stopping acute psychosis in patients with schizophrenia].
    Ivanets NN; Kinkul'kina MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9):47-53. PubMed ID: 21183905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizophrenia and comorbid substance use disorder: effects of antipsychotics.
    Green AI
    J Clin Psychiatry; 2005; 66 Suppl 6():21-6. PubMed ID: 16107180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antidepressive effect of pyridoxine (vitamin B6) in neuroleptic-treated schizophrenic patients with co-morbid minor depression--preliminary open-label trial].
    Shiloh R; Weizman A; Weizer N; Dorfman-Etrog P; Munitz H
    Harefuah; 2001 May; 140(5):369-73, 456. PubMed ID: 11419053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.